Intellia Therapeutics, Inc. (NTLA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Intellia Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.36x | -2.22x | -5.62x | -5.66x | -31.29x | -22.69x |
| P/B Ratio | 1.45x | 1.32x | 2.58x | 2.17x | 8.06x | 5.78x |
| P/S Ratio | 14.40x | 19.91x | 74.61x | 51.53x | 253.61x | 52.52x |
| Profitability | ||||||
| Gross Margin | 76.5% | 82.2% | 75.3% | 85.5% | 79.2% | -159.4% |
| Operating Margin | -651.7% | -923.1% | -1420.5% | -879.0% | -810.4% | -235.5% |
| Net Margin | -609.9% | -896.8% | -1326.5% | -909.8% | -810.5% | -231.5% |
| EBITDA Margin | -586.3% | -905.3% | -1395.8% | -864.5% | -789.5% | -224.6% |
| Liquidity | ||||||
| Current Ratio | 5.08x | 5.77x | 8.67x | 9.61x | 6.11x | 9.59x |
| Quick Ratio | 5.08x | 5.77x | 8.67x | 9.61x | 6.11x | 9.59x |
| Leverage | ||||||
| Debt/Equity | 0.14x | 0.24x | 0.11x | 0.11x | 0.07x | 0.07x |
YoY = year-over-year change. Source: FMP..